These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 4563448)

  • 1. Injected apomorphine and orally administered levodopa in Parkinsonism.
    Düby SE; Cotzias GC; Papavasiliou PS; Lawrence WH
    Arch Neurol; 1972 Dec; 27(6):474-80. PubMed ID: 4563448
    [No Abstract]   [Full Text] [Related]  

  • 2. Unexpected findings with apomorphine and their possible consequences.
    Cotzias GC; Mena I; Papavasiliou PS; Mendez J
    Adv Neurol; 1974; 5():295-9. PubMed ID: 4440577
    [No Abstract]   [Full Text] [Related]  

  • 3. Similarities between neurologic effects of L-dopa and of apomorphine.
    Cotzias GC; Papavasiliou PS; Fehling C; Kaufman B; Mena I
    N Engl J Med; 1970 Jan; 282(1):31-3. PubMed ID: 4901383
    [No Abstract]   [Full Text] [Related]  

  • 4. Levodopa and orphenadrine hydrochloride in Parkinsonism.
    Whyte RK; Hunter KR; Laurence DR; Stern GM; Armitage P
    Eur J Clin Pharmacol; 1971 Dec; 4(1):18-21. PubMed ID: 4948768
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined L-dopa and amantadine in Parkinsonism.
    Pollock M; Jorgensen PB
    Aust N Z J Med; 1972 Aug; 2(3):252-5. PubMed ID: 4564049
    [No Abstract]   [Full Text] [Related]  

  • 6. Augmenting the action of levodopa.
    Rao SK; Vakil SD; Calne DB; Hilson A
    Postgrad Med J; 1972 Nov; 48(565):653-6. PubMed ID: 4568331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MK 486 and levodopa in treatment of Parkinsonism.
    Lieberman AN; Derby BM; Feigenson J; Goodgold A; Nesbitte J; Resurreccion EC; Valdivia F
    Dis Nerv Syst; 1973; 34(4):167-71. PubMed ID: 4711885
    [No Abstract]   [Full Text] [Related]  

  • 8. Levodopa therapy effects on natural history of Parkinsonism.
    Stern PH; McDowell F; Miller JM; Robinson MB
    Arch Neurol; 1972 Dec; 27(6):481-5. PubMed ID: 4628440
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of Levodopa for Parkinsonism. Levodopa (Dopar, Larodopa).
    JAMA; 1971 Mar; 215(12):1969-72. PubMed ID: 4396120
    [No Abstract]   [Full Text] [Related]  

  • 10. Ro 4-4602 and levodopa in the treatment of Parkinsonism.
    Miller EM; Wiener L
    Neurology; 1974 May; 24(5):482-6. PubMed ID: 4857107
    [No Abstract]   [Full Text] [Related]  

  • 11. Parkinsonism-dementia of Guam: treatment with levodopa and L-alpha-methyldopahydrazine.
    Holden EM; Brody JA; Chase TN
    Neurology; 1974 Mar; 24(3):263-5. PubMed ID: 4855953
    [No Abstract]   [Full Text] [Related]  

  • 12. Pyridoxine, DOPA, and Parkinsonism.
    Yahr MD; Duvoisin RC; Côté L; Cohen G
    Adv Biochem Psychopharmacol; 1972; 4():185-94. PubMed ID: 4555927
    [No Abstract]   [Full Text] [Related]  

  • 13. Etilefrine in the treatment of levodopa-induced orthostatic hypotension.
    Miller E; Wiener L; Bloomfield D
    Arch Neurol; 1973 Aug; 29(2):99-103. PubMed ID: 4577820
    [No Abstract]   [Full Text] [Related]  

  • 14. Levodopa in Parkinsonism: potentiation of central effects with a peripheral inhibitor.
    Papavasiliou PS; Cotzias GC; Düby SE; Steck AJ; Fehling C; Bell MA
    N Engl J Med; 1972 Jan; 286(1):8-14. PubMed ID: 4550085
    [No Abstract]   [Full Text] [Related]  

  • 15. Beginning-of-dose motor deterioration following the acute administration of levodopa and apomorphine in Parkinson's disease.
    Merello M; Lees AJ
    J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1024-6. PubMed ID: 1469397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of parkinsonism with L-dopa].
    Melaragno R; Karam GM
    Arq Neuropsiquiatr; 1971 Dec; 29(4):419-27. PubMed ID: 5162186
    [No Abstract]   [Full Text] [Related]  

  • 17. Subcutaneous apomorphine for parkinsonian patients with psychiatric side effects on oral treatment.
    Ray-Chaudhuri K; Abbott RJ; Millac PA
    J Neurol Neurosurg Psychiatry; 1991 Apr; 54(4):372-3. PubMed ID: 2056329
    [No Abstract]   [Full Text] [Related]  

  • 18. Continuous subcutaneous apomorphine as replacement for levodopa in severe parkinsonian patients after surgery.
    Broussolle E; Marion MH; Pollak P
    Lancet; 1992 Oct; 340(8823):859-60. PubMed ID: 1357288
    [No Abstract]   [Full Text] [Related]  

  • 19. Parkinsonism, levodopa, and anesthesia.
    Ngai SH
    Anesthesiology; 1972 Sep; 37(3):344-51. PubMed ID: 4559395
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of Parkinson's disease with Levodopa.
    Calhoun CL
    J Natl Med Assoc; 1972 Nov; 64(6):516-7 passim. PubMed ID: 4639943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.